... Glutamate Neurotransmission in Healthy and Depressed Subjects — Neuropsychopharmacology How Ketamine Acts as ‘Switch’ in the Brain — Penn Today Repurposing Ketamine in Depression and Related Disorders: Can This Enigmatic Drug Achieve Success? ...
... Glutamate Neurotransmission in Healthy and Depressed Subjects — Neuropsychopharmacology How Ketamine Acts as ‘Switch’ in the Brain — Penn Today Repurposing Ketamine in Depression and Related Disorders: Can This Enigmatic Drug Achieve Success? ...
... .; Alan Schatzberg, M.D., professor, psychiatry and behavioral sciences, Stanford University, Stanford, Calif., and former president, American Psychiatric Association; Robert Watson, M.D., owner, Sierra Ketamine Clinics, Reno, Nev.; "Ketamine," Steven Rosenbaum and Jorge Palacios, Oct. 27, 2018, NCBI Bookshelf, U.S. ...
... .; Alan Schatzberg, M.D., professor, psychiatry and behavioral sciences, Stanford University, Stanford, Calif., and former president, American Psychiatric Association; Robert Watson, M.D., owner, Sierra Ketamine Clinics, Reno, Nev.; "Ketamine," Steven Rosenbaum and Jorge Palacios, Oct. 27, 2018, NCBI Bookshelf, U.S. ...
... Injection — Cleveland Clinic Esketamine for Treatment-Resistant Depression — John Hopkins Medicine Ketamine for Major Depression: New Tool, New Questions — Harvard Health Publishing Ketamine and the Future of Rapid-Acting Antidepressants — Annual Review of Clinical Psychology Ketamine for Treatment-Resistant Depression: When and Where Is It Safe? ...
... Injection — Cleveland Clinic Esketamine for Treatment-Resistant Depression — John Hopkins Medicine Ketamine for Major Depression: New Tool, New Questions — Harvard Health Publishing Ketamine and the Future of Rapid-Acting Antidepressants — Annual Review of Clinical Psychology Ketamine for Treatment-Resistant Depression: When and Where Is It Safe? ...